Hamzah Abu‐Sbeih

5.1k total citations
74 papers, 2.0k citations indexed

About

Hamzah Abu‐Sbeih is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hamzah Abu‐Sbeih has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 32 papers in Epidemiology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hamzah Abu‐Sbeih's work include Cancer Immunotherapy and Biomarkers (43 papers), Colorectal Cancer Treatments and Studies (27 papers) and Microscopic Colitis (24 papers). Hamzah Abu‐Sbeih is often cited by papers focused on Cancer Immunotherapy and Biomarkers (43 papers), Colorectal Cancer Treatments and Studies (27 papers) and Microscopic Colitis (24 papers). Hamzah Abu‐Sbeih collaborates with scholars based in United States, China and Australia. Hamzah Abu‐Sbeih's co-authors include Yinghong Wang, Faisal S. Ali, Wei Qiao, Gottumukkala S. Raju, Wenyi Luo, David M. Richards, Adi Diab, Phillip Lum, Tenglong Tang and Mehmet Altan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Hamzah Abu‐Sbeih

69 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamzah Abu‐Sbeih United States 20 1.6k 673 387 234 192 74 2.0k
Clélia Coutzac France 14 1.5k 1.0× 453 0.7× 512 1.3× 346 1.5× 203 1.1× 46 2.2k
Lysiane Marthey France 16 2.2k 1.4× 673 1.0× 396 1.0× 780 3.3× 579 3.0× 33 2.9k
Émilie Soularue France 12 1.5k 1.0× 358 0.5× 433 1.1× 357 1.5× 257 1.3× 28 2.0k
Mathew M. Augustine United States 19 1.2k 0.7× 231 0.3× 646 1.7× 515 2.2× 509 2.7× 45 1.8k
Sameh Mikhail United States 22 747 0.5× 233 0.3× 103 0.3× 415 1.8× 376 2.0× 70 1.5k
Francisco Rodríguez‐Moranta Spain 25 755 0.5× 532 0.8× 133 0.3× 341 1.5× 560 2.9× 88 1.8k
Jean‐Marc Gornet France 22 510 0.3× 665 1.0× 393 1.0× 413 1.8× 715 3.7× 74 1.9k
Jae‐Jun Shim South Korea 22 393 0.2× 463 0.7× 84 0.2× 403 1.7× 334 1.7× 75 1.2k
Sakiko Hiraoka Japan 22 540 0.3× 475 0.7× 180 0.5× 328 1.4× 497 2.6× 121 1.6k
Michael Doukas Netherlands 18 414 0.3× 184 0.3× 105 0.3× 301 1.3× 393 2.0× 66 1.1k

Countries citing papers authored by Hamzah Abu‐Sbeih

Since Specialization
Citations

This map shows the geographic impact of Hamzah Abu‐Sbeih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamzah Abu‐Sbeih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamzah Abu‐Sbeih more than expected).

Fields of papers citing papers by Hamzah Abu‐Sbeih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamzah Abu‐Sbeih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamzah Abu‐Sbeih. The network helps show where Hamzah Abu‐Sbeih may publish in the future.

Co-authorship network of co-authors of Hamzah Abu‐Sbeih

This figure shows the co-authorship network connecting the top 25 collaborators of Hamzah Abu‐Sbeih. A scholar is included among the top collaborators of Hamzah Abu‐Sbeih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamzah Abu‐Sbeih. Hamzah Abu‐Sbeih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Badran, Yousef R., Fangwen Zou, Sienna Durbin, et al.. (2023). Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis. Journal for ImmunoTherapy of Cancer. 11(6). e007195–e007195. 17 indexed citations
3.
Abu‐Sbeih, Hamzah, Tenglong Tang, Faisal S. Ali, et al.. (2023). Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and Proctopathy. Cancers. 15(12). 3160–3160. 4 indexed citations
4.
Atkins, Michael B., Hamzah Abu‐Sbeih, Paolo A. Ascierto, et al.. (2022). Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). Journal for ImmunoTherapy of Cancer. 10(9). e005413–e005413. 7 indexed citations
5.
Abu‐Sbeih, Hamzah, Niharika Mallepally, Tenglong Tang, et al.. (2020). Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy. Journal of Cancer. 11(11). 3144–3150. 14 indexed citations
6.
Tang, Tenglong, Hamzah Abu‐Sbeih, Weijie Ma, et al.. (2020). Gastrointestinal Injury Related to Antiangiogenesis Cancer Therapy. Clinical Colorectal Cancer. 19(3). e117–e123. 6 indexed citations
7.
Abu‐Sbeih, Hamzah, Faisal S. Ali, Wei Qiao, et al.. (2020). Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia. Journal of Cancer. 11(11). 3192–3198. 1 indexed citations
8.
Abu‐Sbeih, Hamzah & Yinghong Wang. (2020). Gut Microbiome and Immune Checkpoint Inhibitor-Induced Enterocolitis. Digestive Diseases and Sciences. 65(3). 797–799. 16 indexed citations
9.
Abu‐Sbeih, Hamzah & Yinghong Wang. (2020). Hepatobiliary Adverse Events. Advances in experimental medicine and biology. 1244. 271–276. 5 indexed citations
10.
Wang, Yinghong, Weijie Ma, Hamzah Abu‐Sbeih, Zhi‐Dong Jiang, & Herbert L. DuPont. (2020). Fecal microbiota transplantation (FMT) for immune checkpoint inhibitor induced–colitis (IMC) refractory to immunosuppressive therapy.. Journal of Clinical Oncology. 38(15_suppl). 3067–3067. 17 indexed citations
11.
Abu‐Sbeih, Hamzah & Yinghong Wang. (2020). Gastrointestinal Tract Adverse Events. Advances in experimental medicine and biology. 1244. 247–253. 5 indexed citations
12.
Abu‐Sbeih, Hamzah, Tenglong Tang, Mehmet Altan, et al.. (2019). Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis. Journal for ImmunoTherapy of Cancer. 7(1). 242–242. 63 indexed citations
13.
Abu‐Sbeih, Hamzah, Faisal S. Ali, & Yinghong Wang. (2019). Immune-checkpoint inhibitors induced diarrhea and colitis. Current Opinion in Gastroenterology. 36(1). 25–32. 24 indexed citations
14.
Abu‐Sbeih, Hamzah, Faisal S. Ali, & Yinghong Wang. (2019). Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients. Current Gastroenterology Reports. 21(3). 8–8. 13 indexed citations
15.
Abu‐Sbeih, Hamzah. (2019). Patients with breast cancer may be at higher risk of colorectal neoplasia. Annals of Gastroenterology. 32(4). 400–406. 8 indexed citations
16.
Abu‐Sbeih, Hamzah, Tenglong Tang, Yang Lü, et al.. (2019). Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury. Journal for ImmunoTherapy of Cancer. 7(1). 31–31. 108 indexed citations
17.
Abu‐Sbeih, Hamzah, Niharika Mallepally, Phillip Lum, et al.. (2019). Patients with Non-Hodgkin’s Lymphoma Are at Risk of Adenomatous Colon Polyps. Digestive Diseases and Sciences. 64(10). 2965–2971. 2 indexed citations
18.
Abu‐Sbeih, Hamzah, Faisal S. Ali, Wenyi Luo, et al.. (2018). Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis. Journal for ImmunoTherapy of Cancer. 6(1). 95–95. 147 indexed citations
19.
Abu‐Sbeih, Hamzah, Faisal S. Ali, Dana Alsaadi, et al.. (2018). Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study. Journal for ImmunoTherapy of Cancer. 6(1). 142–142. 163 indexed citations
20.
Abu‐Sbeih, Hamzah, Faisal S. Ali, Emmanuel Coronel, et al.. (2018). Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia. Gastrointestinal Endoscopy. 89(5). 937–949.e2. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clélia Coutzac Breakdown of academic impact, for papers by Lysiane Marthey Breakdown of academic impact, for papers by Émilie Soularue Breakdown of academic impact, for papers by Mathew M. Augustine Breakdown of academic impact, for papers by Sameh Mikhail Breakdown of academic impact, for papers by Francisco Rodríguez‐Moranta Breakdown of academic impact, for papers by Jean‐Marc Gornet Breakdown of academic impact, for papers by Jae‐Jun Shim Breakdown of academic impact, for papers by Sakiko Hiraoka Breakdown of academic impact, for papers by Michael Doukas
Rankless by CCL
2026